Cell line · CVCL_S471
Papers33
1 to 20 of 33
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Non-Temperature-Induced Antitumor Effects of Amplitude-Modulated Radiofrequency: Molecular and Functional Synergies with Radiotherapy. | Cancers (Basel) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Differential Replication and Oncolytic Effects of Zika Virus in Aggressive CNS Tumor Cells: Insights from Organoid and Tumoroid Models. | Viruses | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Temozolomide promotes matrix metalloproteinase 9 expression through p38 MAPK and JNK pathways in glioblastoma cells. | Sci Rep | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Progesterone Receptor Membrane Component 1 (PGRMC1) Modulates Tumour Progression, the Immune Microenvironment and the Response to Therapy in Glioblastoma. | Cells | 2023 | Its Methods give the RRID and name the line | PubMed | |
| CCDC85A is regulated by miR-224-3p and augments cancer cell resistance to endoplasmic reticulum stress. | Front Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| STAT3 Enhances Sensitivity of Glioblastoma to Drug-Induced Autophagy-Dependent Cell Death. | Cancers (Basel) | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Homozygous MTAP deletion in primary human glioblastoma is not associated with elevation of methylthioadenosine. | Nat Commun | 2021 | Its Methods give the RRID and name the line | PubMed | |
| Impaired anaplerosis is a major contributor to glycolysis inhibitor toxicity in glioma. | Cancer Metab | 2021 | Its Methods give the RRID and name the line | PubMed | |
| RNA sequencing data of different grade astrocytoma cell lines. | Data Brief | 2021 | Cellosaurus cites it | PubMed | |
| An enolase inhibitor for the targeted treatment of ENO1-deleted cancers. | Nat Metab | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Robust detection of oncometabolic aberrations by 1H-13C heteronuclear single quantum correlation in intact biological specimens. | Commun Biol | 2020 | Its Methods give the RRID and name the line | PubMed | |
| Origin of the U87MG glioma cell line: Good news and bad news. | Sci Transl Med | 2016 | Cellosaurus cites it | PubMed | |
| Elucidating the cancer-specific genetic alteration spectrum of glioblastoma derived cell lines from whole exome and RNA sequencing. | Oncotarget | 2015 | Cellosaurus cites it | PubMed | |
| Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies. | Sci Data | 2014 | Cellosaurus cites it | PubMed | |
| DNA fingerprinting of glioma cell lines and considerations on similarity measurements. | Neuro Oncol | 2012 | Cellosaurus cites it | PubMed | |
| MAP kinase-interacting kinase 1 regulates SMAD2-dependent TGF-β signaling pathway in human glioblastoma. | Cancer Res | 2011 | Cellosaurus cites it | PubMed | |
| Inhibitory effect of pisosterol on human glioblastoma cell lines with C-MYC amplification. | J Appl Toxicol | 2011 | Cellosaurus cites it | PubMed | |
| Detection of multiple gene amplifications in glioblastoma multiforme using array-based comparative genomic hybridization. | Lab Invest | 2001 | Cellosaurus cites it | PubMed | |
| Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. | Brain Pathol | 1999 | Cellosaurus cites it | PubMed | |
| Overexpression of protein kinase C epsilon in astroglial brain tumor derived cell lines and primary tumor samples. | Int J Oncol | 1999 | Cellosaurus cites it | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_S471/papers